Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...

Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...

AI unit, has placed strict controls over the release of its research papers to maintain its competitive edge in ...

Google DeepMind CEO Demis Hassabis's AI journey had an unexpected start: his early mastery of chess. Years before Hassabis ...

Google DeepMind launches TxGemma, open AI models to speed up drug discovery, enhance predictions, and support multi-step ...

In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). To learn more, check ...

Investing.com-- Google’s (NASDAQ: GOOGL) artificial intelligence research arm, DeepMind, has imposed stricter controls on the ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...

World Cup-winning former footballer Cesc Fabregas and Google DeepMind co-founder Sir Demis Hassabis have been added to the ...

This thinking capability was first introduced by Google in its Gemini 2.0 Flash Thinking Experimental AI model, which was ...